The purpose of the protocol is to assess the responder rate as defined by the achievement of the primary goal from the Goal Attainment Scale following one botulinum toxin type-A (BoNT-A) injection cycle in accordance with routine practices.
Study Type
OBSERVATIONAL
Enrollment
100
Hospital Maritimo de Oza
A Coruña, Spain
Hospital de Cruces
Barakaldo, Spain
Responder rate as defined by the achievement of the primary goal from the Goal Attainment Scale (GAS).
Assessed using the Goal Attainment Scale (GAS).
Time frame: Between 1 and 3 months from inclusion
Overall attainment of treatment goals
Assessed using the GAS T-Score.
Time frame: Between 1 and 3 months from inclusion
The use of standardized outcome measures and their results (e.g. muscle tone reduction, pain scores, functional tests).
Time frame: Up to 5 months
Description of injection practices (BoNT-A: doses, volume, injection points, electromyography, electrostimulation and ecography).
Time frame: Up to 5 months
Global assessment of benefits by both the investigator and the subject (or guardian).
Assessed using a 5-point scale - much worse/worse/unchanged/better/much better
Time frame: Up to 5 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hospital Clinic i Provincial de Barcelona
Barcelona, Spain
Hospital de Bellvitge
Barcelona, Spain
Hospital Mutua de Terrassa
Barcelona, Spain
Hospital Sant Pau
Barcelona, Spain
Hospital Vall Hebron
Barcelona, Spain
Hospital Puerta del Mar
Cadiz, Spain
Hospital de Magdalena
Castellon, Spain
Hospital de Gorliz
Gorraiz, Spain
...and 14 more locations